SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-24-006617
Filing Date
2024-11-14
Accepted
2024-11-14 16:32:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC p24-3179sc13ga.htm SC 13G/A 56259
  Complete submission text file 0000902664-24-006617.txt   58259
Mailing Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ
Business Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100
Kiniksa Pharmaceuticals International, plc (Subject) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90491 | Film No.: 241463253
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address OFFICE #122, WINDWARD 3 BUILDING REGATTA OFFICE PARK, WEST BAY ROAD GRAND CAYMAN E9 KY1-9006
Business Address OFFICE #122, WINDWARD 3 BUILDING REGATTA OFFICE PARK, WEST BAY ROAD GRAND CAYMAN E9 KY1-9006 (345) 749-8643
HHLR ADVISORS, LTD. (Filed by) CIK: 0001762304 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A